Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study

NCT02223208 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT02223208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02223208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2014
Completion date
March 25, 2026
Enrollment
89 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

alk- anaplastic large cell lymphoma (alcl), angioimmunoblastic t-cell lymphoma (aitl), nodal peripheral t-cell lymphoma of t follicular helper cell origin, peripheral t-cell lymphomas (ptcl), ptcl-nos